NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
128 hedge funds and large institutions have $690M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 53 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 123 → 128 (+5)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
128
Holding in Top 10
5
Calls
$7.99M
Puts
$1.35M
Top Buyers
| 1 | +$29.6M | |
| 2 | +$23.5M | |
| 3 | +$11.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.49M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.14M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$2.75M | |
| 3 | -$2.36M | |
| 4 |
PGH
Partners Group Holding
Baar-Zug,
Switzerland
|
-$2.27M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$1.72M |